NNIT A/S: 4/2017 Novo Nordisk renews corporate core IT infrastructure agreement with NNIT

Udgivet den 04-05-2017  |  kl. 17:12  |  

Company announcement 4/2017
Søborg/Copenhagen, May 4, 2017

Novo Nordisk renews corporate core IT infrastructure agreement with NNIT

NNIT A/S (NNIT), a leading provider of IT services and consultancy announces that it has entered into a 6-year-agreement with Novo Nordisk, replacing an existing corporate core IT infrastructure outsourcing contract between the two parties, covering global services, including support and maintenance of Novo Nordisk's corporate core IT infrastructure.

While the parties' existing five-year-contract initially commenced on January 1, 2013 with expiration December 31, 2017, the renewed contract will take effect from January 1, 2017 and run until December 31, 2022. The agreement replaces the existing contract for 2017 and the new agreement represents a total value of around DKK 1bn.

Jacob Hahn Michelsen, Senior Vice President and Head of Client Management at NNIT says about the agreement: The renewal of our existing contract re-confirms the long-standing, strong and trusted cooperation between Novo Nordisk and NNIT. The agreement is a testament to the services and quality NNIT delivers, and further consolidates the robustness of our business.  

The agreement increases NNIT's backlog for 2018 and 2019, but does not change NNIT's guidance for 2017 or the long-term targets.

Enquiries
Investor contacts:
Jesper Wagener, Head of Investor Relations: +45 3075 5392, jvwa@nnit.com

Media contacts:
Helga Heyn, Press relations: +45 3077 8141, hhey@nnit.com 
Rikke Dalager, Head of Communications: +45 3077 8080, rida@nnit.com

About NNIT
NNIT A/S is one of Denmark's leading IT service providers and consultancies. NNIT A/S offers a wide range of IT services and solutions to its customers, primarily in the life sciences sector in Denmark and internationally and to customers in the public, enterprise and finance sectors in Denmark. As of December 31, 2016, NNIT A/S had 2,809 employees. For more information please visit www.nnit.com.

NN IA extention UK


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: NNIT A/S via Globenewswire

\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

12:45 Novo ser flere begrænsninger i studie der kæder supersællerter sammen med sjælden øjenlidelse
12:41 Skeptisk Pandora-analytiker ser fortsat pres på aktien - andre ser potentiale
12:30 Obligationer/middag: Marginal rentestigning mens USA holder fri
11:56 Aktier middag: Zealand i rekord i afdæmpet men positivt marked
11:32 B&O har sikret opbakning til at hente nye penge
11:17 USA/Danske: Kongetallet fredag kan give store bølgeskvulp på finansmarkederne
09:45 Topdanmark får sænket anbefalingen hos Danske Bank op til regnskab
09:27 Obligationer/åbning: Lidt højere rente op til tungt tal fredag
09:22 Aktier/åbning: Banker i toppen af lysegrønt C25
09:14 Mærsk får løftet kursmålet hos Kepler - fortsat negativ anbefaling
09:01 Torm får indledt dækningen hos Arctic Securities med købsanbefaling
08:31 Aktier/tendens: Stille svag positiv dag i udsigt - B&O har leveret regnskab
07:57 Obligationer/tendens: Renter ventes at køre sidelæns på amerikansk lukkedag før jobrapport
07:49 Råvarer: Oliepriserne falder på grund af tegn på en langsommere amerikansk økonomi
07:44 Vestas får sænket anbefalingen hos spansk storbank
07:40 Pandora/RBC: Kursmål sænkes til 920 kr. fra 1050 kr. - fortsat "underperform"
06:45 Asien: Stigninger med tyngden lagt på teknologi
06:34 B&O: Vil accelerere væksten og forhøje kapitalen med 20 pct.
06:34 B&O: Havde mindre fremgang i salget i fjerde kvartal
06:34 Novo Nordisks storsællert forbundet med sjældent synstab i studie